schizandrin b has been researched along with apatinib in 1 studies
| Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (apatinib) | Trials (apatinib) | Recent Studies (post-2010) (apatinib) |
|---|---|---|---|---|---|
| 321 | 1 | 218 | 575 | 109 | 544 |
| Protein | Taxonomy | schizandrin b (IC50) | apatinib (IC50) |
|---|---|---|---|
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, CY; Dong, ST; Dong, ZJ; Li, YJ; Liu, HT; Meng, L; Wang, LS; Xing, XQ; Xue, CJ | 1 |
1 other study(ies) available for schizandrin b and apatinib
| Article | Year |
|---|---|
The synergistic anti-tumor effect of schisandrin B and apatinib.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclooctanes; Lignans; Molecular Structure; Polycyclic Compounds; Pyridines | 2020 |